Thyroid pathologies in nuclear medicine

The presented work describes the thyroid pathologies and nuclear-medical diagnostic approach, in order to obtain a differential diagnosis monitoring of various neoplasms; specifically, it importance radiometabolic treatment with iodine 131, after thyroidectomy surgery. Through study conducted patients suffering from disease, undergoing metabolic radiotherapy, is shown that, equal distribution radioiodine, uptake at least 3700 MBq therapeutic dose obtained. All this can be seen through whole body scintigraphic framework, obtained use double-headed gamma camera collimators for high emission energies. Radiometabolic effective risk relapse, while radioiodine not recommended low-risk patients.